Dudley Robert Michael
Insider CIK 1854161 · RNAZ Chief Executive Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNAZ Transcode Therapeutics, In | P Buy | 2023-09-28 | 2023-10-02 | 98,000 | $0.51 | $50.0K | 180,262 | SEC↗ |
| RNAZ Transcode Therapeutics, In | P Buy | 2023-06-21 | 2023-06-22 | 12,000 | $2.65 | $31.8K | 82,262 | SEC↗ |
| RNAZ Transcode Therapeutics, In | P Buy | 2023-06-20 | 2023-06-22 | 6,607 | $2.55 | $16.8K | 70,262 | SEC↗ |
| RNAZ Transcode Therapeutics, In | P Buy | 2023-06-09 | 2023-06-13 | 19,000 | $2.76 | $52.4K | 912,114 | SEC↗ |
| RNAZ Transcode Therapeutics, In | P Buy | 2023-06-09 | 2023-06-14 | 19,000 | $2.76 | $52.4K | 61,155 | SEC↗ |
| RNAZ Transcode Therapeutics, In | A Award deriv | 2023-05-19 | 2023-05-19 | 735,000 | — | $0 | 735,000 | SEC↗ |
| RNAZ Transcode Therapeutics, In | A Award deriv | 2022-12-12 | 2022-12-14 | 135,000 | — | $0 | 135,000 | SEC↗ |
| RNAZ Transcode Therapeutics, In | P Buy | 2022-09-14 | 2022-09-16 | 20,000 | $1.15 | $23.0K | 893,114 | SEC↗ |
| RNAZ Transcode Therapeutics, In | P Buy | 2022-05-31 | 2022-06-01 | 2,000 | $1.87 | $3.7K | 873,114 | SEC↗ |
| RNAZ Transcode Therapeutics, In | P Buy | 2022-05-27 | 2022-06-01 | 28,000 | $1.84 | $51.5K | 871,114 | SEC↗ |
| RNAZ Transcode Therapeutics, In | A Award deriv | 2022-02-01 | 2022-02-03 | 135,000 | — | $0 | 135,000 | SEC↗ |